The Executive Director of US Market Access Strategy will lead the integrated market access strategy for BMS’s Oncology portfolio (both for inline and pipeline hematology and oncology assets), including oversight of US market access strategy development and execution. Reporting directly to the SVP, Oncology, this highly strategic role will partner closely with his/her Commercial counterpart(s) for the Oncology portfolio to inform access strategy development and oversee its execution. You will partner with senior leaders of Commercial, Medical, and to optimally position BMS products for success in a continuously evolving US market access landscape. You will oversee a team of colleagues who will be accountable for different market access elements including Access Strategy as well understanding how US fits into the global market. This role will need to work with US policy and pricing to determine short- and long-term strategy for the oncology portfolio. This role will be working with business development to get US market access assumptions to determine deal analytics. This role will also be leading oncology strategy for IRA, MFN and other possible policy issues that affect pricing and access of oncology products. A motivated, adaptable, inclusive and decisive disposition is essential for success in this role. A strong candidate should be highly informed on all aspects of market access, have a track record of making complex strategic decisions, leading cross-functional teams, and communicating effectively to senior leaders to reach alignment across the organization.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive